MedPath

Pfizer Canada Ulc

🇨🇦Canada
Ownership
Subsidiary
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

1.1k

CANADA:540

Drug Approvals

TALZENNA

Approval Date
May 16, 2025
CANADA

TALZENNA

Approval Date
May 16, 2025
CANADA

IXIFI

Approval Date
Apr 1, 2025
CANADA

ABRYSVO

Approval Date
May 22, 2024
CANADA

VELSIPITY

Approval Date
Apr 18, 2024
CANADA

NURTEC ODT

Approval Date
Mar 25, 2024
CANADA

LITFULO

Approval Date
Feb 13, 2024
CANADA

ELREXFIO

Approval Date
Jan 23, 2024
CANADA

ELREXFIO

Approval Date
Jan 23, 2024
CANADA

ABRILADA

Approval Date
Mar 13, 2023
CANADA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 54
  • Next

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.